![]()
MIRA INFORM REPORT
|
Report Date : |
24.02.2011 |
IDENTIFICATION DETAILS
|
Correct Name : |
SUAN FARMA SOCIEDAD ANONIMA |
|
|
|
|
Registered Office : |
Calle De Einstein, 8, 28108 |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2009 |
|
|
|
|
Date of Incorporation : |
|
|
|
|
|
Legal Form : |
Joint Stock Company |
|
|
|
|
Line of Business : |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
Maximum Credit Limit : |
323.869,00 € |
|
|
|
|
Status : |
Moderate |
|
|
|
|
Payment
Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30, 2010
|
Country Name |
Previous Rating (01.04.2010) |
Current Rating (30.06.2010) |
|
|
a2 |
a2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
SUAN FARMA SOCIEDAD ANONIMA
TAX NUMBER: A80624067
Identification
Current Business Name: SUAN FARMA SOCIEDAD ANONIMA
Commercial Name: SUANLAB
Other names: YES
Current Address: CALLE DE EINSTEIN, 8
Branches: 4
Telephone number: 913446890 Fax: 913446894
URL: www.suanfarma.com
Corporate e-mail: suanfarma@suanfarma.com
Credit Appraisal: 323.869,00 €
Incidents: YES
R.A.I.: NO
Bank and business defaults of payment - ASNEF INDUSTRIAL: NO
Balance sheet latest sales (2009): 36.236.485,00 € (Trade Register)
Result: 366.931 €
Total Assets: 22.954.145 €
Social Capital: 1.000.050,00 €
Employees: 27
Listed on a Stock Exchange: NO
Incorporation date: 28/05/1993
Activity: Wholesale of pharmaceutical products
NACE 2009 CODE: 4646
International Operations: Imports and
Exports
President:
Parent Company:
Participations: 10
Latest filed accounts published in the Mercantile Register: 2009
Type of Accounts available at the Mercantile Register: Individuals
Latest act published in BORME: 18/01/2011 Appointments
Latest press article: 30/11/2010 EXPANSIÓN (PRODUCTS
AND ACTIVITIES)
Bank Entities: There are
The date when this report was last updated is 21/02/2011.
The information contained in this report has been investigated and
contrasted on 21/02/2011
Maximum Credit
(from 0 to 6,000,000
€)
Favourable to 323.869,00 €
Exercise:2009
|
Treasury |
Restrained |
|
Indebtedness |
Important |
|
Profitability |
Average |
|
Balance |
Bad |
|
Incidents |
None or Negligible |
|
Business
Trajectory |
Excellent |
Summary
LEGAL ACTIONS: No legal actions registered
ADMINISTRATIVE CLAIMS: 2 ( Last:22/12/2009 , first:
22/12/2009 )
|
|
|
|
|
With the Social Security: |
2 |
|
|
With the Tax Authorities: |
0 |
|
|
With Other Official bodies: |
0 |
|
AFFECTED BY: No significant element.
Figures expressed in €
WITH THE SOCIAL SECURITY.
Notifications
|
DATE |
ORGANIZATION |
AMOUNT |
|
22/12/2009 |
CENTRAL TREASURY FOR SOCIAL SECURITY DIRECCION PROVINCIAL DE
TRABAJO Y SEGURIDAD SOCIAL |
896,66 |
|
22/12/2009 |
CENTRAL TREASURY FOR SOCIAL SECURITY DIRECCION PROVINCIAL DE
TRABAJO Y SEGURIDAD SOCIAL |
896,66 |
There are 2 administrative claims with the Social Security
registered
Figures expressed in €
Notifications
WITH THE SOCIAL SECURITY.
Phase: DEBTS WITH OFFICIAL BODIES
Organization: CENTRAL TREASURY FOR SOCIAL SECURITY DIRECCION
PROVINCIAL DE TRABAJO Y SEGURIDAD SOCIAL
Concept: Share
Date of the claim: 22/12/2009
Period: 0309 0309
Source: Published in the Gazette of MADRID Appendix 01, on 22/12/2009, page 3
Amount: 896,66
Figures expressed in €
Notifications
WITH THE SOCIAL SECURITY.
Phase: DEBTS WITH OFFICIAL BODIES
Organization: CENTRAL TREASURY FOR SOCIAL SECURITY DIRECCION
PROVINCIAL DE TRABAJO Y SEGURIDAD SOCIAL
Concept: Share
Date of the claim: 22/12/2009
Period: 0409 0409
Source: Published in the Gazette of MADRID Appendix 01, on 22/12/2009, page 3
Amount: 896,66
BANK AND BUSINESS
DEFAULTS OF PAYMENT - ASNEF INDUSTRIAL ![]()
COMPANY NOT REGISTERED IN THE R.A.I.
This company is not registered in the Disputed Bills register (R.A.I.)
DATE AND TIME OF THE CONSULTATION
15/02/2011 09:02:26
Information from the Registro de Aceptaciones Impagados (RAI)- Disputed
Bills register.
It can only be used for information legitimate needs of the consulting
party, in accordance with its social or business activity, in order to grant a
credit or the monitoring or control of the already granted credits and can not
be transmitted or communicated to thirds, nor copied, duplicated, reproduced
nor implemented to any database , owned or external, or reused it in anyway,
direct or indirectly.
FINANCIAL ELEMENTS
The shaded amounts in the following financial statements have been converted to the norms established in the PGC2007 derived from RD 1514/2007 and 1515/2007, this way comparatives could be shown with the amounts of exercises initiated from 1/01/08.
Figures given in €
|
|
31/12/2009 (12) BALANCE SHEET |
% ASSETS |
31/12/2008 (12) BALANCE SHEET |
% ASSETS |
31/12/2007 (12) BALANCE SHEET |
% ASSETS |
|
ASSETS |
|
|
|
|
|
|
|
A) NON CURRENT ASSETS |
8.675.293,00 |
37,79 |
5.659.138,00 |
29,30 |
5.221.652,16 |
28,51 |
|
B) CURRENT ASSETS |
14.278.852,00 |
62,21 |
13.657.458,00 |
70,70 |
13.093.359,46 |
71,49 |
|
LIABILITIES |
|
|
|
|
|
|
|
A) NET WORTH |
3.383.852,00 |
14,74 |
3.472.700,00 |
17,98 |
3.804.649,79 |
20,77 |
|
B) NON CURRENT LIABILITIES |
4.943.622,00 |
21,54 |
1.980.433,00 |
10,25 |
2.782.714,60 |
15,19 |
|
C) CURRENT LIABILITIES |
14.626.671,00 |
63,72 |
13.863.463,00 |
71,77 |
11.727.647,23 |
64,03 |
Profit and Loss
Account Analysis ![]()
Figures given in €
|
|
31/12/2009 (12) BALANCE SHEET |
% NET TURNOVER |
31/12/2008 (12) BALANCE SHEET |
% NET TURNOVER |
31/12/2007 (12) BALANCE SHEET |
% NET TURNOVER |
|
SALES |
36.236.485,00 |
|
33.234.919,00 |
|
33.938.992,32 |
|
|
GROSS MARGIN |
6.551.722,00 |
18,08 |
6.727.623,00 |
20,24 |
6.242.994,02 |
18,39 |
|
EBITDA |
359.692,00 |
0,99 |
530.900,00 |
1,60 |
487.888,28 |
1,44 |
|
EBIT |
339.847,00 |
0,94 |
603.860,00 |
1,82 |
320.879,14 |
0,95 |
|
NET RESULT |
366.931,00 |
1,01 |
565.733,00 |
1,70 |
455.603,26 |
1,34 |
|
EFFECTIVE TAX RATE (%) |
18,11 |
|
11,32 |
|
21,38 |
|
Values table
Figures expressed in %
|
|
COMPANY (2009) |
SECTOR |
DIFFERENCE |
|
BALANCE SHEET ANALYSIS: % on the total
assets |
|
|
|
|
ASSETS |
|
|
|
|
A) NON CURRENT ASSETS |
37,79 |
22,56 |
15,24 |
|
A) CURRENT ASSETS |
62,21 |
77,44 |
-15,24 |
|
LIABILITIES |
|
|
|
|
A) NET WORTH |
14,74 |
41,22 |
-26,48 |
|
B) NON CURRENT LIABILITIES |
21,54 |
8,37 |
13,17 |
|
C) CURRENT LIABILITIES |
63,72 |
50,42 |
13,31 |
|
|
|
|
|
|
|
COMPANY (2009) |
SECTOR |
DIFFERENCE |
|
PROFIT AND LOSS ACCOUNT ANALYSIS: % on the total
operating income |
|
|
|
|
SALES |
99,79 |
98,58 |
1,21 |
|
GROSS MARGIN |
18,04 |
34,83 |
-16,78 |
|
EBITDA |
0,99 |
6,62 |
-5,63 |
|
EBIT |
0,94 |
4,87 |
-3,93 |
|
NET RESULT |
1,01 |
3,59 |
-2,58 |
Compared sector (NACE 2009): 4646
Number of companies: 112
Size (Sales Figure): 7,000,000.00 - 40,000,000.00 Euros
Results
Distribution
Source: annual financial report 2009
Figures given in €
|
DISTRIBUTION BASE |
APPLICATION A |
||
|
Profit and Loss Account Balance |
366.930,64 |
Legal Reserve |
0,00 |
|
Carry over |
0,00 |
Goodwill reserve |
0,00 |
|
Voluntary reserves |
0,00 |
Special reserves |
0,00 |
|
Other reserves disposable at will |
0,00 |
Voluntary reserves |
166.930,64 |
|
Total of Amounts to be distributed |
366.930,64 |
Dividends |
200.000,00 |
|
|
|
Carry over and others |
0,00 |
|
|
|
Compensation of previous exercises losses |
0,00 |
|
|
|
Application total |
366.930,64 |
Auditing
Source: filing of annual financial statement 2009
Auditors’ opinion: FAVOURABLE
Auditor: ATTEST SERVICIOS EMPRESARIALES S.L.
Auditing fees: 18.700,00 €
Facts subsequent
to the closing
Source: Annual financial report 2009
Ya con efectos primero de Enero de 2010, se ha producido el nombramiento
de D. Francisco Fernández que venía desempeñando las funciones de Director
Comercial desde el año 2006 como Director General, pasando D. Miguel Ara, que
ha dirigido la empresa desde el año 1999, a desempeñar las funciones de
Director General del Grupo Suanfarma, puesto de nueva creación
Current Legal Seat Address:
CALLE DE EINSTEIN, 8
28108
Previous Seat Address:
CALLE ISABEL COLBRAND 10 - 3 PLT OF 113 114
28050
|
STREET |
POSTAL CODE |
TOWN |
PROVINCE |
|
CALLE TORREBLANCA, 10 |
08970 |
SANT JOAN DESPI |
|
|
CALLE BRAVO MURILLO, 377 |
28020 |
|
|
|
CALLE FERNAN GONZALEZ, 56 |
28009 |
|
|
|
CALLE SAN ROQUE, 12 |
28140 |
FUENTE EL SAZ DE JARAMA |
|
There are 4 branches registered
ADMINISTRATIVE
LINKS
Main Board
members, Directors and Auditor ![]()
|
POSITION |
NAME AND SURNAME |
APPOINTMENT DATE |
|
|
PRESIDENT |
ARA SANZ HECTOR |
10/12/2010 |
|
|
VICE-PRESIDENT |
FERNANDEZ FUSTER MANUEL |
10/12/2010 |
|
|
MEMBER OF THE BOARD |
ARA PARGA MIGUEL |
10/12/2010 |
|
|
AUDITOR |
APPOINTMENT DATE |
||
|
ATTEST SERVICIOS EMPRESARIALES SLP |
11/02/2010 |
||
There are 4 board members, directors and auditors registered
In case you need more information you can request:Board Members Monitoring
Board members
remuneration
Source: Annual financial report 2009
Board members remuneration: 0,00 €
Functional
Managers
|
POSITION |
NAME AND SURNAME |
|
General Manager |
ARA PARGA MIGUEL |
|
Financial Director |
VIDAL RODRIGUEZ LUIS |
|
Human Resources Director |
VIDA LUIS |
|
|
BUSINESS NAME |
CIF / COUNTRY |
% |
SOURCE |
DATE REP. |
|
|
ARA SANZ HECTOR |
|
80,00 |
OWN SOURCES |
15/07/2010 |
|
|
FERNANDEZ FUSTER MANUEL |
|
10,00 |
OWN SOURCES |
15/07/2010 |
|
|
ARA PRAGA MIGUEL |
|
10,00 |
OWN SOURCES |
15/07/2010 |
There are 3 direct financial links through shareholders
registered
|
|
BUSINESS NAME |
CIF / COUNTRY |
% |
SOURCE |
DATE REP. |
|
|
ARA SANZ IGNACIO |
|
5,00 |
TRADE REG. |
15/07/2010 |
|
|
BUSINESS NAME |
CIF / COUNTRY |
% |
SOURCE |
DATE REP. |
|
|
LABOSUAN INVESTIGACION Y DESARROLLO SL. |
B86105459 |
100,00 |
B.O.R.M.E. |
21/01/2011 |
|
|
INMUEBLES SUANFARMA SL. |
B86105426 |
100,00 |
B.O.R.M.E. |
28/01/2011 |
|
|
PLANTAS MEDICINALES DE CATALUNA SA |
A60386539 |
80,00 |
OWN SOURCES |
21/02/2011 |
|
|
SUAN FARMA C A |
|
80,00 |
TRADE REG. |
31/12/2009 |
|
|
SUAN FARMA INC |
UNITED STATES |
80,00 |
TRADE REG. |
31/12/2009 |
|
|
ALBERTO GIRONELLA, S.A. DE C.V. |
|
69,97 |
TRADE REG. |
31/12/2009 |
|
|
TORREFARMA S.L. |
B83346122 |
50,00 |
OWN SOURCES |
21/02/2011 |
|
|
ANGEL BIOTECHNOLOGY LTD |
|
3,40 |
OWN SOURCES |
21/02/2011 |
|
|
BIOSEARCH SA |
A18550111 |
0,33 |
TRADE REG. |
31/12/2008 |
|
|
SUANFARMA BIOTECH S.G.E.C.R. S.A. |
A85184703 |
Indef. |
OWN SOURCES |
21/02/2011 |
|
|
BUSINESS NAME |
CIF / COUNTRY |
% |
SOURCE |
DATE REP. |
|
|
FARMAPROJECTS, SA |
A58692997 |
30,00 |
TRADE REG. |
31/12/1996 |
|
|
3 P BIOPHARMACEUTICALS S.L. |
B31875800 |
6,79 |
TRADE REG. |
31/12/2007 |
|
|
EXXENTIA GRUPO FITOTERAPEUTICO S.A. (EXTINGUIDA) |
A81166258 |
3,00 |
EL ECONOMISTA |
24/01/2008 |
Company with rating inferior to 7
Search for Link by
Administrator ![]()
Search Criterion: ”ARA SANZ HECTOR “
|
COMPANY |
POSITION |
PROVINCE |
|
SUANFARMA BIOTECH S.G.E.C.R. S.A. |
Presidente |
|
|
IBERSUAN S.L. |
Presidente |
|
|
BIOANTIEDAD |
Presidente |
|
|
INMUEBLES SUANFARMA SL. |
Presidente |
|
|
DISTRIMSA SA |
Presidente |
|
In case you need more information you can request:Board Members
Monitoring
Search Criterion: ”SUAN FARMA SOCIEDAD ANONIMA”
URL: www.suanfarma.com
SUANFARMA
URL: www.suanfarma.com
SUANFARMA
URL: www.suanfarma.com
SUANFARMA SA SUAN FARMA, S.A. markets and distributes
active pharmaceutical ingredient ...
URL: www.suanfarma.com
Suan Farma, S.A. comercializa y distribuye intermedios y materias ... SUAN FARMA,
S.A. is a private Spanish company founded in 1993. The company ...
URL: www.suanfarmabiotech.com
socios - SUANFARMA Biotech SUANFARMA, SA (1993), dedicada al
comercialización de materias primas para el sector de medicamentos genéricos
para la industria farmacéutica y veterinaria. ...
Incorporation date: 28/05/1993
Establishment date: 01/01/1993
Founder’s Name: LA TITULAR ES FUNDADORA INICIAL DEL NEGOCIO
Activity: Wholesale of pharmaceutical products
NACE 2009 CODE: 4646
NACE 2009 Activity: Wholesale of pharmaceutical goods
Business: IMPORTACION, EXPORTACION Y COMPRAVENTA AL POR MAYOR
Y AL POR MENOR DE PRODUCTOS QUIMICOS FARMACEUTICOS Y ESPECIALIDADES PARA USOS
HUMANO Y VETERINARIO.
Activity description: COMERCIALIZACION Y DISTRIBUCION DE
PRINCIPIOS ACTIVOS FARMACEUTICOS PARA USO HUMANO Y VETERINARIO.
Latest employees figure: 27 (2010)
% of fixed employees: 100,00%
% of men: 59,38%
% of women: 40,62%
|
|
Source: Annual financial report 2009
|
CATEGORY |
AVERAGE NUMBER OF EMPLOYEES |
MEN |
WOMEN |
|
Distribution by sexes |
|
19 |
13 |
PURCHASES
Imports from: TODO EL MUNDO
SALES
Exports to: TODO EL MUNDO
SUPPLIERS
|
BUSINESS NAME |
INTERNATIONAL |
|
SUAN FARMA INC |
YES |
|
TORREFARMA S.L. |
NO |
|
SUAN FARMA
BITECH S.C.G.R. |
YES |
|
SUAN FARMA SA |
NO |
|
PLAMECA SL |
NO |
There are 5 Suppliers
CLIENTS
|
BUSINESS NAME |
INTERNATIONAL |
|
PLAMECA SL |
NO |
|
SUAN FARMA
BIOTECH S.C.G.R. |
YES |
|
TORREFARMA S.L. |
NO |
|
SUAN FARMA INC |
YES |
|
SUAN FARMA |
YES |
There are 5 Clients
Professional and advertising services ![]()
Source: Annual financial report 2009
Professional services expenses: 1.798.268,00 €
Advertising services expenses: 204.648,00 €
|
ENTITY |
BRANCH |
ADDRESS |
TOWN OR CITY |
PROVINCE |
|
|
9400 |
AVDA. BRUSELAS, 12 |
|
|
|
BANCO ESPAÑOL DE CREDITO, S.A. |
|
|
|
|
|
BANCO PASTOR, S.A. |
|
|
|
|
|
DEUTSCHE BANK, S.A.E. |
|
|
|
|
|
BANCO SANTANDER, S.A. |
|
|
|
|
There are 10 bank entities registered
Discount facilities: 0
Credit policy: 1
Mortgage loan: 0
Loans with no real security: 0
|
Debt type: Credit policy |
Granted limit:400.000,00 € Used limit:300.439,00 € Available limit:99.561,00
€ Source: Filed
Accounts (2009) |
|
|
|
There are 1 bank operations registered
FORMER NAMES:
•
FLAVINE ESPANA SOCIEDAD ANONIMA.
Brand name: DEO-NATURAL (Valid)
Type: JOINT Scope: NATIONAL Date: 15/11/2002
Name: SUANLAB (Valid)
Type: DENOMINATIVE Scope: NATIONAL
Date: 17/03/2009
Name: LABOSUAN (Valid)
Type: DENOMINATIVE Scope: NATIONAL
Date: 17/03/2009
Name: SUANFARMA (Valid)
Type: DENOMINATIVE Scope: NATIONAL
Date: 21/03/2006
Name: SUANFARMA BIOTECH (Valid)
Type: DENOMINATIVE Scope: NATIONAL
Date: 16/03/2006
There are 6 brands, signs and commercial names
Constitution Data
Register Date: 28/05/1993
Register town:
Announcement number: 262754
Legal form: Joint-stock Company
Social Capital: 1.000.050,00 €
Paid-up capital: 1.000.050,00 €
Obligation to fill in Financial Statements: YES
Chamber census: YES (2009)
(OFFICIAL COMPANIES
REGISTRY GAZETTE) ![]()
· Acts on activity: 0
· Acts on administrators: 19 (Last: 18/01/2011, first: 20/07/1993)
· Acts on capital: 2 (Last: 14/11/2007, first: 14/11/2007)
· Acts on creation: 1 (Last: 20/07/1993)
· Acts on filed accounts: 24 (Last: 01/12/2010, first: 25/07/1995)
· Acts on identification: 3 (Last: 12/02/2010, first: 12/11/1996)
· Acts on Information: 3 (Last: 24/02/1997, first: 12/11/1996)
Latest acts in
B.O.R.M.E.
Other acts
|
ACT |
DATE |
NOTICE NUM. |
TRADE REGISTER |
|
Appointments |
18/01/2011 |
18268 |
|
|
Re-elections |
10/12/2010 |
454985 |
|
|
Resignations |
10/11/2010 |
413914 |
|
|
Appointments |
15/04/2010 |
150410 |
|
|
Change of registered address |
12/02/2010 |
61486 |
|
|
Appointments |
11/02/2010 |
59919 |
|
|
Capital enlargement |
14/11/2007 |
561018 |
|
|
Capital enlargement |
14/11/2007 |
561018 |
|
Latest filed accounts
|
ACT |
DATE |
NOTICE NUM. |
TRADE REGISTER |
|
Annual Filed Accounts (2009) |
01/12/2010 |
1117903 |
|
|
Annual Filed Accounts (2009) consolidated |
19/11/2010 |
1062189 |
|
|
Annual Filed Accounts (2008) consolidated |
18/11/2009 |
873226 |
|
There are 52 acts registered
Press summary by
type of information (last five years) ![]()
Legal notices: 1 (Last: 22/01/2010)
Structural Data: 3 (Last: 19/09/2007, first: 27/01/2006)
Informative data: 1 (Last: 27/11/2009)
Financial Information: 0
Negative information: 0
Business lines: 3 (Last: 30/11/2010, first: 08/09/2006)
Historical press releases: 6 (Last: 05/05/2005, first: 22/07/1995)
Latest press
article published ![]()
30/11/2010 EXPANSIÓN (Page 16) PRODUCTS AND
ACTIVITIES
SUANFARMA prepara su segundo fondo de capital riesgo, con el que espera
levantar alrededor de 40 millones de euros para invertir en pymes innovadoras
de base biotecnológica. La gestora cerrará en los próximos días el tramo
institucional, que podría llegar a los 15 millones de euros.
SUANFARMA nació en la industria de los medicamentos genéricos,
22/01/2010 EXPANSIÓN - LEGAL ANNOUNCEMENTS
LA JUNTA GRAL. EXTRAORDINARIA Y UNIVERSAL DE ESTA SDAD., CELEBRADA EL
DIA 22/12/09, ACORDO TRASLADAR EL DOMICILIO SOCIAL DE LA CIUDAD DE MADRID A
27/11/2009 EL ECONOMISTA - GENERAL INFORMATION
EL GRUPO SUANFARMA PRESENTO EL 26/11/09 SU NUEVO CENTRO DE
EMPRENDIMIENTO E INCUBACION DE EMPRESAS EN SU SEDE DE
19/09/2007 EXPANSIÓN - SHAREHOLDERS AND HOLDINGS
SUAN FARMA Y UN GRUPO DE EJECUTIVOS
30/06/2007 EXPANSIÓN - SHAREHOLDERS AND HOLDINGS
LA SDAD. PARA EL DESARROLLO DE NAVARRA (SODENA) HA ENTRADO COMO SOCIO
PROMOTOR, CON UN 24% DE LAS ACCIONES, EN LA CIA 3P BIOPHARMACEUTICALS, PROYECTO
EMPRESARIAL ENFOCADO A CREAR LA PRIMERA PLANTA EN ESPAÑA DE PRODUCCION DE
PROTEINAS TERAPEUTICAS PARA LABORATORIOS Y EMPRESAS FARMACEUTICAS. LA
COMPOSICION DEL ACCIONARIADO DE 3P BIOPHARMACEUTICALS QUEDA CONFORMADO POR
SODENA (24%), LOS SOCIOS TECNOLOGICOS (SUAN FARMA, IDIFARMA Y DRO BIOSYSTEMS)
CON EL 31,4% Y LOS SOCIOS FINANCIEROS, ENTRE ELLOS CAJA NAVARRA, CAJA RURAL DE
NAVARRA Y UNIVERSIDAD DE NAVARRA, CON EL 45% RESTANTE. EL PLAN DE NEGOCIO DE LA
NUEVA PLANTA CONTEMPLA UNA INVERSION DE 9 MM.
There are 14 press articles registered for this company
Financial Information
Por causas ajenas a nuestra voluntad el Depósito de cuentas
El balance cerrado a 31/12/2003 (Depósito 2003) está disponible en
INFORMA, pero no ha sido cargado por presentar en sus cuentas la siguiente
anomalía: toda la información del Balance y de la cuenta de Pérdidas y
Ganancias presenta errores en sus datos.
The information on the last account contained in this report is extracted from the Mercantile Register file of the legal address of the Company and dated 22/12/2010.
The shaded amounts in the following financial statements have been converted to the norms established in the PGC2007 derived from RD 1514/2007 and 1515/2007, this way comparatives could be shown with the amounts of exercises initiated from 1/01/08.
This theoretical conversion exercise has been carried out from the financial statements contained in the accounting information presented on the Trade Register, and elaborated under the accounting norms and principles collected in PGC90 derived from RD 1643/1990, not taking into account any other type of information; for this reason the conversion exercise could include certain inaccuracies.
SITUATION BALANCE-SHEET
Assets
Figures given in €
|
|
31/12/2009 (12) |
% ASSETS |
31/12/2008 (12) |
% ASSETS |
31/12/2007 (12) |
% ASSETS |
|
A) NON CURRENT ASSETS |
8.675.293,00 |
37,79 |
5.659.138,00 |
29,30 |
5.221.652,16 |
28,51 |
|
I. Intangible assets |
|
|
|
|
0,00 |
0,00 |
|
II. Tangible fixed assets |
5.086.405,00 |
22,16 |
1.781.371,00 |
9,22 |
1.729.471,37 |
9,44 |
|
1. Property, plant and equipment |
4.840.960,00 |
21,09 |
966.893,00 |
5,01 |
|
|
|
2. Technical fittings and other tangible assets |
245.445,00 |
1,07 |
40.151,00 |
0,21 |
|
|
|
3. Fixed assets in progress and advances |
|
|
774.327,00 |
4,01 |
|
|
|
III. Real-estate investments |
|
|
|
|
|
|
|
IV. Long term investments in associated and affiliated companies |
2.383.507,00 |
10,38 |
2.784.038,00 |
14,41 |
3.483.693,27 |
19,02 |
|
1. Net worth instruments |
1.808.507,00 |
7,88 |
1.895.108,00 |
9,81 |
3.483.693,27 |
19,02 |
|
2. Credits to companies |
575.000,00 |
2,50 |
888.930,00 |
4,60 |
|
|
|
V. Long Term Financial Investments |
1.177.684,00 |
5,13 |
1.025.045,00 |
5,31 |
8.487,52 |
0,05 |
|
1. Net worth instruments |
1.039.468,00 |
4,53 |
938.237,00 |
4,86 |
|
|
|
5. Other financial assets |
22.146,00 |
0,10 |
2.088,00 |
0,01 |
8.487,52 |
0,05 |
|
6. Other investments |
116.070,00 |
0,51 |
84.720,00 |
0,44 |
|
|
|
VI. Assets by deferred taxes |
27.697,00 |
0,12 |
68.684,00 |
0,36 |
|
|
|
VII. Non current commercial debts |
|
|
|
|
|
|
|
B) CURRENT ASSETS |
14.278.852,00 |
62,21 |
13.657.458,00 |
70,70 |
13.093.359,46 |
71,49 |
|
I. Non-current assets maintained for sale |
|
|
|
|
|
|
|
II. Stocks |
4.202.462,00 |
18,31 |
3.045.344,00 |
15,77 |
2.448.279,86 |
13,37 |
|
1. Goods available for sale |
4.201.521,00 |
18,30 |
2.968.904,00 |
15,37 |
|
|
|
6. Pre-payments to suppliers |
941,00 |
0,00 |
76.440,00 |
0,40 |
|
|
|
III. Trade Debtors and other receivable accounts |
9.708.629,00 |
42,30 |
10.036.330,00 |
51,96 |
9.933.331,51 |
54,24 |
|
1. Clients |
8.939.654,00 |
38,95 |
9.609.405,00 |
49,75 |
8.806.561,62 |
48,08 |
|
b) Clients for sales and short term services
rendering |
8.939.654,00 |
38,95 |
9.609.405,00 |
49,75 |
|
|
|
2. Clients group and associated companies |
114.928,00 |
0,50 |
103.400,00 |
0,54 |
7.349,93 |
0,04 |
|
3. Other debts |
225.282,00 |
0,98 |
48.717,00 |
0,25 |
885.422,97 |
4,83 |
|
4. Staff |
3.131,00 |
0,01 |
6.631,00 |
0,03 |
57.335,00 |
0,31 |
|
5. Assets by current taxes |
54.838,00 |
0,24 |
56.233,00 |
0,29 |
|
|
|
6. Other credits with the Public Administrations |
370.796,00 |
1,62 |
211.944,00 |
1,10 |
176.661,99 |
0,96 |
|
IV. Short term investments in associated and affiliated companies |
|
|
|
|
|
|
|
V. Short term financial investments |
42.000,00 |
0,18 |
|
|
|
|
|
5. Other financial assets |
42.000,00 |
0,18 |
|
|
|
|
|
VI. Short term periodifications |
|
|
|
|
|
|
|
VII. Cash and equivalents |
325.761,00 |
1,42 |
575.784,00 |
2,98 |
711.748,09 |
3,89 |
|
1. Treasury |
325.761,00 |
1,42 |
575.784,00 |
2,98 |
711.748,09 |
3,89 |
|
TOTAL ASSETS (A + B) |
22.954.145,00 |
100,00 |
19.316.596,00 |
100,00 |
18.315.011,62 |
100,00 |
Alerts associated to the conversion to PGC2007
The valuation norms applicable to financial
instruments has changed substantially and, for this reason the conversion of
financial statements from PGC90 to PGC2007 could include notable inaccuracy.
In the conversion process there has
been estimated that the total item 124080 “Provisions” according to PGC90 is
associated to “Net Worth Instruments”.
In the conversion process there has
been estimated that the total item 143070 “Provisions on debtors” according to
PGC90, for %1, is associated to “Clients for sales and services rendering”.
Net Worth and
Liabilities
Figures given in €
|
|
31/12/2009 (12) |
% ASSETS |
31/12/2008 (12) |
% ASSETS |
31/12/2007 (12) |
% ASSETS |
|
A) NET WORTH |
3.383.852,00 |
14,74 |
3.472.700,00 |
17,98 |
3.804.649,79 |
20,77 |
|
A-1) Equity |
3.383.852,00 |
14,74 |
3.472.700,00 |
17,98 |
3.804.649,79 |
20,77 |
|
I. Capital |
1.000.050,00 |
4,36 |
1.000.050,00 |
5,18 |
1.000.050,07 |
5,46 |
|
1. Authorized capital |
1.000.050,00 |
4,36 |
1.000.050,00 |
5,18 |
1.000.050,07 |
5,46 |
|
II. Issue premium |
|
|
|
|
|
|
|
III. Reserves |
2.216.871,00 |
9,66 |
2.106.917,00 |
10,91 |
2.348.996,46 |
12,83 |
|
1. Legal and statutory |
200.010,00 |
0,87 |
200.010,00 |
1,04 |
200.010,01 |
1,09 |
|
2. Other funds |
2.016.861,00 |
8,79 |
1.906.907,00 |
9,87 |
2.148.986,45 |
11,73 |
|
IV. (Net worth own shares and participations) |
|
|
|
|
|
|
|
V. Results from previous years |
|
|
|
|
|
|
|
VI. Other loans from partners |
|
|
|
|
|
|
|
VII. Exercise Result |
366.931,00 |
1,60 |
565.733,00 |
2,93 |
455.603,26 |
2,49 |
|
VIII. (Interim dividend) |
-200.000,00 |
-0,87 |
-200.000,00 |
-1,04 |
|
|
|
IX. Other net worth instruments |
|
|
|
|
|
|
|
A-2) Value changes adjustments |
|
|
|
|
|
|
|
I. Financial assets available for sale |
|
|
|
|
|
|
|
II. Coverage operations |
|
|
|
|
|
|
|
III. Non-current assets and related liabilities, maintained for sale |
|
|
|
|
|
|
|
IV. Conversion differences |
|
|
|
|
|
|
|
V. Other |
|
|
|
|
|
|
|
A-3) Received legacies, grants and subventions |
|
|
|
|
|
|
|
B) NON CURRENT LIABILITIES |
4.943.622,00 |
21,54 |
1.980.433,00 |
10,25 |
2.782.714,60 |
15,19 |
|
I. Long term provisions |
306.070,00 |
1,33 |
84.720,00 |
0,44 |
58.108,50 |
0,32 |
|
1. Long term staff benefits obligations |
116.070,00 |
0,51 |
84.720,00 |
0,44 |
58.108,50 |
0,32 |
|
4. Other provisions |
190.000,00 |
0,83 |
|
|
|
|
|
II. Long term debts |
4.545.499,00 |
19,80 |
1.895.713,00 |
9,81 |
2.724.606,10 |
14,88 |
|
2. Debts with bank entities |
4.433.775,00 |
19,32 |
1.895.713,00 |
9,81 |
2.724.606,10 |
14,88 |
|
3. Financial leasing creditors |
111.724,00 |
0,49 |
|
|
|
|
|
III. Long term debts with associated and affiliated companies |
|
|
|
|
|
|
|
IV. Liabilities by deferred taxes |
92.053,00 |
0,40 |
|
|
|
|
|
V. Long term periodifications |
|
|
|
|
|
|
|
VI. Non current trade creditors |
|
|
|
|
|
|
|
VII. Long term debts with special characteristics |
|
|
|
|
|
|
|
C) CURRENT LIABILITIES |
14.626.671,00 |
63,72 |
13.863.463,00 |
71,77 |
11.727.647,23 |
64,03 |
|
I. Liabilities related with non-current assets maintained for sale |
|
|
|
|
|
|
|
II. Short term provisions |
|
|
|
|
|
|
|
III. Short term debts |
6.420.505,00 |
27,97 |
5.053.882,00 |
26,16 |
4.117.233,15 |
22,48 |
|
2. Debts with bank entities |
6.382.768,00 |
27,81 |
5.053.882,00 |
26,16 |
4.117.233,15 |
22,48 |
|
3. Financial leasing creditors |
27.187,00 |
0,12 |
|
|
|
|
|
5. Other financial liabilities |
10.550,00 |
0,05 |
|
|
|
|
|
IV. Short term debts with associated and affiliated companies |
|
|
|
|
|
|
|
V. Trade creditors and other payable accounts |
8.206.166,00 |
35,75 |
8.809.581,00 |
45,61 |
7.610.414,08 |
41,55 |
|
1. Suppliers |
6.108.100,00 |
26,61 |
6.728.667,00 |
34,83 |
6.948.978,67 |
37,94 |
|
b) Short term suppliers |
6.108.100,00 |
26,61 |
6.728.667,00 |
34,83 |
|
|
|
2. Suppliers group and associated companies |
430.901,00 |
1,88 |
124.422,00 |
0,64 |
|
|
|
3. Different creditors |
1.295.933,00 |
5,65 |
1.261.402,00 |
6,53 |
|
|
|
4. Staff (pending remunerations) |
276.993,00 |
1,21 |
563.098,00 |
2,92 |
572.753,59 |
3,13 |
|
6. Other debts with Public Administrations |
93.838,00 |
0,41 |
131.590,00 |
0,68 |
87.928,25 |
0,48 |
|
7. Clients pre-payments |
401,00 |
0,00 |
402,00 |
0,00 |
753,57 |
0,00 |
|
VI. Short term periodifications |
|
|
|
|
|
|
|
VII. Short term debts with special characteristics |
|
|
|
|
|
|
|
TOTAL NET WORTH AND LIABILITIES (A + B + C) |
22.954.145,00 |
100,00 |
19.316.596,00 |
100,00 |
18.315.011,62 |
100,00 |
Alerts associated to the conversion to PGC2007
In the conversion process it has not been
possible to breakdown the composition of liabilities originated by debts with
the public administrations; for this reason the mentioned amounts are presented
fully aggregated in the item “other debts with the public administrations”
Figures given in €
|
|
31/12/2009 (12) |
%ING. EXPLOT. |
31/12/2008 (12) |
%ING. EXPLOT. |
31/12/2007 (12) |
%ING. EXPLOT. |
|
A) CONTINUED OPERATIONS |
|
|
|
|
|
|
|
1. Net Turnover |
36.236.485,00 |
99,79 |
33.234.919,00 |
99,55 |
33.938.992,32 |
99,56 |
|
A) Sales |
35.751.710,00 |
98,46 |
32.951.202,00 |
98,70 |
33.691.374,48 |
98,83 |
|
b) Services provided |
484.775,00 |
1,34 |
283.717,00 |
0,85 |
247.617,84 |
0,73 |
|
2. Variation in stocks of finished goods and work in progress |
|
|
|
|
|
|
|
3. Works for its own assets |
|
|
|
|
|
|
|
4. Supplies |
-29.759.805,00 |
-81,96 |
-26.656.888,00 |
-79,85 |
-27.845.647,86 |
-81,69 |
|
a) Material consumed |
-29.663.676,00 |
-81,69 |
-26.670.454,00 |
-79,89 |
-27.746.867,82 |
-81,40 |
|
b) Raw materials consumed |
-9.855,00 |
-0,03 |
-11.768,00 |
-0,04 |
-1.551,68 |
0,00 |
|
c) Works carried out for other companies |
-93.034,00 |
-0,26 |
-20.995,00 |
-0,06 |
-61.856,36 |
-0,18 |
|
d) Deterioration on merchandises, raw materials and other supplies |
6.760,00 |
0,02 |
46.329,00 |
0,14 |
-35.372,00 |
-0,10 |
|
5. Other operating income |
75.042,00 |
0,21 |
149.592,00 |
0,45 |
149.649,56 |
0,44 |
|
a) Other incomes |
14.018,00 |
0,04 |
|
|
101.330,27 |
0,30 |
|
b) Operating grants included in the exercise result |
61.024,00 |
0,17 |
149.592,00 |
0,45 |
48.319,29 |
0,14 |
|
6. Labour cost |
-2.408.632,00 |
-6,63 |
-2.520.799,00 |
-7,55 |
-3.348.234,17 |
-9,82 |
|
a) Wages and similar expenses |
-1.968.080,00 |
-5,42 |
-2.141.360,00 |
-6,41 |
|
|
|
b) Social costs |
-440.552,00 |
-1,21 |
-379.439,00 |
-1,14 |
|
|
|
7. Other operating costs |
-3.619.862,00 |
-9,97 |
-3.531.145,00 |
-10,58 |
-2.478.150,57 |
-7,27 |
|
a) External services |
-3.596.080,00 |
-9,90 |
-3.555.911,00 |
-10,65 |
-2.429.618,80 |
-7,13 |
|
b) Taxes |
-19.130,00 |
-0,05 |
-24.344,00 |
-0,07 |
-6.014,82 |
-0,02 |
|
c) Losses, deterioration and variation on business operations provisions |
-4.652,00 |
-0,01 |
49.110,00 |
0,15 |
-35.907,00 |
-0,11 |
|
d) Other day to day expenses |
|
|
|
|
-6.609,95 |
-0,02 |
|
8. Amortization of fixed assets |
-21.953,00 |
-0,06 |
-22.479,00 |
-0,07 |
-48.691,14 |
-0,14 |
|
9. Allocation of subventions on non financial investments and other |
|
|
|
|
|
|
|
10. Provisions excess |
|
|
|
|
|
|
|
11. Deterioration and result for fixed assets disposal |
|
|
-59.979,00 |
-0,18 |
-47.039,00 |
-0,14 |
|
a) Deteriorations and losses |
|
|
|
|
-47.039,00 |
-0,14 |
|
b) Results for disposals and others |
|
|
-59.979,00 |
-0,18 |
|
|
|
12. Negative difference of business combinations |
|
|
|
|
|
|
|
13. Other results |
-161.428,00 |
-0,44 |
10.639,00 |
0,03 |
|
|
|
A.1) OPERATING RESULT (1 + 2 + 3 + 4 + 5 + 6 + 7 + 8 + 9 + 10 + 11 +
12 + 13) |
339.847,00 |
0,94 |
603.860,00 |
1,81 |
320.879,14 |
0,94 |
|
14. Financial income |
7.382,00 |
0,02 |
132.899,00 |
0,40 |
14.561,02 |
0,04 |
|
a) From net worth instruments participations |
7.382,00 |
0,02 |
132.899,00 |
0,40 |
|
|
|
a 1) On group and associated companies |
|
|
103.872,00 |
0,31 |
|
|
|
a 2) On third parties |
7.382,00 |
0,02 |
29.027,00 |
0,09 |
|
|
|
b) From negotiable values and other financial instruments |
|
|
|
|
14.561,02 |
0,04 |
|
b 2) From third parties |
|
|
|
|
14.561,02 |
0,04 |
|
15. Financial expenses |
-103.895,00 |
-0,29 |
-225.701,00 |
-0,68 |
-211.739,04 |
-0,62 |
|
a) For debts with associated and affiliated companies |
|
|
|
|
-209.669,28 |
-0,62 |
|
b) For debts with third parties |
-103.895,00 |
-0,29 |
-225.701,00 |
-0,68 |
-2.069,76 |
-0,01 |
|
16. Reasonable value variation on financial instruments |
60.014,00 |
0,17 |
|
|
|
|
|
a) Negotiation portfolio and others |
60.014,00 |
0,17 |
|
|
|
|
|
17. Exchange differences |
160.580,00 |
0,44 |
-117.239,00 |
-0,35 |
455.795,54 |
1,34 |
|
18. Deterioration and result for disposal of financial instruments |
-15.864,00 |
-0,04 |
244.125,00 |
0,73 |
|
|
|
a) Deteriorations and losses |
-15.864,00 |
-0,04 |
-596.638,00 |
-1,79 |
|
|
|
b) Results for disposals and others |
|
|
840.763,00 |
2,52 |
|
|
|
19. Other financial income and expenses |
|
|
|
|
|
|
|
A.2) FINANCIAL RESULT (14 + 15 + 16 + 17 + 18 + 19) |
108.217,00 |
0,30 |
34.084,00 |
0,10 |
258.617,52 |
0,76 |
|
A.3) RESULT BEFORE TAXES (A.1 + A.2) |
448.064,00 |
1,23 |
637.944,00 |
1,91 |
579.496,66 |
1,70 |
|
20. Taxes on profits |
-81.133,00 |
-0,22 |
-72.211,00 |
-0,22 |
-123.893,40 |
-0,36 |
|
A.4) EXERCISE RESULT COMING FROM CONTINUED OPERATIONS (A.3 + 20) |
366.931,00 |
1,01 |
565.733,00 |
1,69 |
455.603,26 |
1,34 |
|
B) DISCONTINUED OPERATIONS |
|
|
|
|
|
|
|
21. Net of taxes exercise result coming from discontinued operations |
|
|
|
|
|
|
|
A.5) EXERCISE RESULT (A.4 + 21) |
366.931,00 |
1,01 |
565.733,00 |
1,69 |
455.603,26 |
1,34 |
Alerts associated to the conversion to PGC2007
Valuation norms applicable to Financial
instruments collected in PGC2007 present notable changes with respect to PGC90.
As a consequence, the conversion of the financial statements of the accounts to
PGC2007, carried out considering mainly classification changes in the accounts
might contain certain inaccuracies.
Status of recognized
income and expenses
Figures given in €
|
NET WORTH CHANGES (1/3) |
31/12/2009 (12) |
31/12/2008 (12) |
|
A) PROFIT AND LOSS ACCOUNT RESULT |
366.931,00 |
565.733,00 |
|
INCOME AND EXPENSES ALLOCATED DIRECTLY TO NET WORTH |
|
|
|
|
|
|
|
II. Cash flow coverage |
|
|
|
III. Received legacies, grants and subventions |
|
|
|
IV. For actuarial profits and losses and other adjustments |
|
|
|
V. Non-current assets and related liabilities, maintained for sale |
|
|
|
VI. Conversion differences |
|
|
|
VII. Tax effect |
|
|
|
B) TOTAL INCOME AND EXPENSES ALLOCATED DIRECTLY TO NET WORTH (I + II +
III + IV +V+VI+VII) |
|
|
|
PROFIT AND LOSS ACCOUNT TRANSFERS |
|
|
|
VIII. For valuation of financial instruments |
|
|
|
IX. Cash flow coverage |
|
|
|
X. Received legacies, grants and subventions |
|
|
|
XI. Non-current assets and related liabilities, maintained for sale |
|
|
|
XII. Conversion differences |
|
|
|
XIII. Tax effect |
|
|
|
C) TOTAL TRANSFERS TO THE PROFIT AND LOSS ACCOUNT (VIII + IX + X + XI+
XII+ XIII) |
|
|
|
TOTAL INCOME AND EXPENSES RECOGNIZED (A + B + C) |
366.931,00 |
565.733,00 |
Total net worth
changes status
Figures given in €
|
NET WORTH CHANGES ( 2 /3) |
AUTHORIZED CAPITAL |
RESERVES |
EXERCISE RESULT |
(INTERIM DIVIDEND) |
|
FINAL ACCOUNT BALANCE OF EXERCISE (2007) |
1.000.050,00 |
2.348.996,00 |
357.921,00 |
|
|
I. Adjustments by change of criteria in the exercise (2007) |
|
|
|
|
|
II. Adjustments by errors in the exercise (2007) |
|
|
|
|
|
ADJUSTED ACCOUNT BALANCE, BEGINNING OF EXERCISE (2008) |
1.000.050,00 |
2.348.996,00 |
357.921,00 |
|
|
I. Total recognized income and expenses |
|
|
565.733,00 |
|
|
II. Operations with partners or owners |
|
-600.000,00 |
|
-200.000,00 |
|
4. (-) Dividends distribution |
|
-600.000,00 |
|
-200.000,00 |
|
III. Other net worth variations |
|
357.921,00 |
-357.921,00 |
|
|
FINAL ACCOUNT BALANCE OF EXERCISE (2008) |
1.000.050,00 |
2.106.917,00 |
565.733,00 |
-200.000,00 |
|
I. Adjustments by change of criteria in the exercise (2008) |
|
|
|
|
|
II. Adjustments by errors in the exercise (2008) |
|
|
-121.119,00 |
|
|
ADJUSTED ACCOUNT BALANCE, BEGINNING OF EXERCISE (2009) |
1.000.050,00 |
2.106.917,00 |
444.614,00 |
-200.000,00 |
|
I. Total recognized income and expenses |
|
|
366.931,00 |
|
|
II. Operations with partners or owners |
|
|
-300.000,00 |
|
|
4. (-) Dividends distribution |
|
|
-300.000,00 |
|
|
III. Other net worth variations |
|
109.954,00 |
-144.614,00 |
|
|
FINAL ACCOUNT BALANCE OF EXERCISE (2009) |
1.000.050,00 |
2.216.871,00 |
366.931,00 |
-200.000,00 |
|
NET WORTH CHANGES ( 3 /3) |
TOTAL |
|
||
|
FINAL ACCOUNT BALANCE OF EXERCISE (2007) |
3.706.967,00 |
|
||
|
I. Adjustments by change of criteria in the exercise (2007) |
|
|
||
|
II. Adjustments by errors in the exercise (2007) |
|
|
||
|
ADJUSTED ACCOUNT BALANCE, BEGINNING OF EXERCISE (2008) |
3.706.967,00 |
|
||
|
I. Total recognized income and expenses |
565.733,00 |
|
||
|
II. Operations with partners or owners |
-800.000,00 |
|
||
|
4. (-) Dividends distribution |
-800.000,00 |
|
||
|
III. Other net worth variations |
|
|
||
|
FINAL ACCOUNT BALANCE OF EXERCISE (2008) |
3.472.700,00 |
|
||
|
I. Adjustments by change of criteria in the exercise (2008) |
|
|
||
|
II. Adjustments by errors in the exercise (2008) |
-121.119,00 |
|
||
|
ADJUSTED ACCOUNT BALANCE, BEGINNING OF EXERCISE (2009) |
3.351.581,00 |
|
||
|
I. Total recognized income and expenses |
366.931,00 |
|
||
|
II. Operations with partners or owners |
-300.000,00 |
|
||
|
4. (-) Dividends distribution |
-300.000,00 |
|
||
|
III. Other net worth variations |
-34.660,00 |
|
||
|
FINAL ACCOUNT BALANCE OF EXERCISE (2009) |
3.383.852,00 |
|
||
Figures given in €
|
|
31/12/2009 (12) |
31/12/2008 (12) |
|
A) CASH FLOW COMING FROM OPERATING ACTIVITIES |
|
|
|
1. exercise result before taxes |
448.064,00 |
637.944,00 |
|
2. Results adjustments |
257.556,00 |
-88.468,00 |
|
a) Amortization of fixed assets (+) |
21.953,00 |
22.479,00 |
|
b) Value correction for deterioration (+/-) |
9.104,00 |
|
|
e) Results for decline and disposal of fixed assets (+/-) |
|
-184.146,00 |
|
g) Financial income (-) |
-7.382,00 |
-132.899,00 |
|
f) Financial expenses (+) |
103.895,00 |
209.574,00 |
|
j) Reasonable value variation on financial instruments (+/-) |
-60.014,00 |
|
|
k) Other income and expenses (-/+) |
190.000,00 |
-3.476,00 |
|
3. Changes in current capital |
-728.902,00 |
-623.115,00 |
|
a) Stocks (+/-) |
-1.150.359,00 |
-597.064,00 |
|
b) Debtors and other receivable accounts (+/-) |
330.097,00 |
-1.216.763,00 |
|
c) Other current assets (+/-) |
-42.000,00 |
|
|
d) Creditors and other payable accounts (+/-) |
-605.810,00 |
1.190.712,00 |
|
e) Other current liabilities (+/-) |
739.170,00 |
|
|
4. Other cash flow coming from operating activities |
-84.179,00 |
-255.433,00 |
|
a) Interests payments (-) |
-91.561,00 |
-225.701,00 |
|
c) Interests collections (+) |
7.382,00 |
29.027,00 |
|
d) Collections (payments) for profit tax (+/-) |
|
-75.153,00 |
|
e) Other payments (collections) (-/+) |
|
16.394,00 |
|
5. Cash flow coming from operating activities (1 + 2 + 3 + 4) |
-107.461,00 |
-329.072,00 |
|
B) CASH FLOW COMING FROM INVESTING ACTIVITIES |
|
|
|
6. Investment payments (-) |
-3.410.651,00 |
-737.476,00 |
|
a) Group and associated companies |
|
-78.000,00 |
|
c) Tangible assets |
-3.360.171,00 |
-557.876,00 |
|
e) Other financial assets |
-50.480,00 |
-101.600,00 |
|
7. Disinvestment collections (+) |
270.000,00 |
1.711.441,00 |
|
c) Tangible assets |
|
645.258,00 |
|
e) Other financial assets |
270.000,00 |
1.066.183,00 |
|
8. Cash Flow in investment activities (6 + 7) |
-3.140.651,00 |
973.965,00 |
|
C) CASH FLOW COMING FROM FINANCING ACTIVITIES |
|
|
|
9. Net worth instruments collections and payments |
|
|
|
10. Financial liabilities instruments collections and payments |
3.298.089,00 |
19.143,00 |
|
a) Issue |
3.699.941,00 |
500.000,00 |
|
2. Debts with bank entities (+) |
3.699.941,00 |
500.000,00 |
|
b) Return and amortization of |
-401.852,00 |
-480.857,00 |
|
2. Debts with bank entities (-) |
-401.852,00 |
-480.857,00 |
|
11. Payments for dividends and remunerations of other net worth
instruments |
-300.000,00 |
-800.000,00 |
|
a) Dividends (-) |
-300.000,00 |
-800.000,00 |
|
12. Cash Flow in financing activities (9 + 10 + 11) |
2.998.089,00 |
-780.857,00 |
|
D) Exchange rate variations effect |
|
|
|
E) NET CASH OR EQUIVALENTS INCREASE / REDUCTION (5 + 8 + 12 + D) |
-250.023,00 |
-135.964,00 |
|
Cash or equivalents at the beginning of the exercise |
575.784,00 |
711.748,00 |
|
Cash or equivalents at the end of the exercise |
325.761,00 |
575.784,00 |
|
|
31/12/2009 (12) |
CHANGE % |
31/12/2008 (12) |
CHANGE % |
31/12/2007 (12) |
|
BALANCE RATIOS |
|||||
|
Working Capital (€) |
-347.819,00 |
-68,84 |
-206.005,00 |
-115,08 |
1.365.712,23 |
|
Working capital ratio |
-0,02 |
0,00 |
-0,01 |
-112,50 |
0,08 |
|
Soundness Ratio |
0,39 |
-36,07 |
0,61 |
-16,44 |
0,73 |
|
Average Collection Period (days) |
96 |
-11,26 |
109 |
3,07 |
105 |
|
Average Payment Period (days) |
89 |
-15,75 |
105 |
16,33 |
90 |
|
LIQUIDITY RATIOS |
|||||
|
Current Ratio (%) |
97,62 |
-0,90 |
98,51 |
-11,77 |
111,64 |
|
Quick Ratio (%) |
2,51 |
-39,52 |
4,15 |
-31,63 |
6,07 |
|
DEBT RATIOS |
|||||
|
Borrowing percentage (%) |
47,77 |
32,77 |
35,98 |
-3,69 |
37,36 |
|
External Financing Average Cost |
0,01 |
-66,67 |
0,03 |
0,00 |
0,03 |
|
Debt Service Coverage |
-102,05 |
-383,19 |
-21,12 |
-255,64 |
13,57 |
|
Interest Coverage |
3,27 |
22,01 |
2,68 |
76,32 |
1,52 |
|
GENERAL AND ACTIVITIES RATIOS |
|||||
|
Auto financing generated by sales (%) |
-0,30 |
69,70 |
-0,99 |
-166,44 |
1,49 |
|
Auto financing generated by Assets (%) |
-0,47 |
72,35 |
-1,70 |
-161,82 |
2,75 |
|
Breakdown Point |
1,01 |
-0,98 |
1,02 |
0,99 |
1,01 |
|
Average Sales Volume per Employee |
1.132.390,16 |
-8,00 |
1.230.922,93 |
16,06 |
1.060.593,51 |
|
Average Cost per Employee |
75.269,75 |
-19,38 |
93.362,93 |
-10,77 |
104.632,32 |
|
Assets Turnover |
1,58 |
-8,14 |
1,72 |
-7,03 |
1,85 |
|
Inventory Turnover (days) |
51 |
23,68 |
41 |
29,55 |
32 |
|
RESULTS RATIOS |
|||||
|
Return on Assets (ROA) (%) |
1,48 |
-52,72 |
3,13 |
78,86 |
1,75 |
|
Operating Profitability (%) |
1,58 |
-46,08 |
2,93 |
66,48 |
1,76 |
|
Return on Equity (ROE) (%) |
13,24 |
-27,93 |
18,37 |
20,62 |
15,23 |
Balance Sheet and
Financial Balance
Figures expressed in %
|
|
COMPANY (2009) |
SECTOR |
DIFFERENCE |
|
BALANCE SHEET ANALYSIS: % on the total
assets |
|
|
|
|
ASSETS |
|||
|
A) NON CURRENT ASSETS |
37,79 |
22,56 |
15,24 |
|
A) CURRENT ASSETS |
62,21 |
77,44 |
-15,24 |
|
LIABILITIES |
|||
|
A) NET WORTH |
14,74 |
41,22 |
-26,48 |
|
B) NON CURRENT LIABILITIES |
21,54 |
8,37 |
13,17 |
|
C) CURRENT LIABILITIES |
63,72 |
50,42 |
13,31 |
|
|
|
|
|
Analytical Account
of Results
Figures given in %
|
|
COMPANY (2009) |
SECTOR |
DIFFERENCE |
|
Net Turnover |
99,79 |
98,58 |
1,21 |
|
Other operating income |
0,21 |
1,42 |
-1,21 |
|
OPERATING INCOME |
100,00 |
100,00 |
0,00 |
|
Supplies |
-81,96 |
-65,34 |
-16,62 |
|
Variation in stocks of finished goods and work in progress |
|
0,17 |
|
|
GROSS MARGIN |
18,04 |
34,83 |
-16,79 |
|
Other operating costs |
-9,97 |
-14,32 |
4,35 |
|
Labour cost |
-6,63 |
-14,25 |
7,62 |
|
GROSS OPERATING RESULT |
1,44 |
6,26 |
-4,82 |
|
Amortization of fixed assets |
-0,06 |
-1,42 |
1,36 |
|
Deterioration and result for fixed assets disposal |
|
0,03 |
|
|
Other expenses / income |
-0,44 |
|
|
|
NET OPERATING RESULT |
0,94 |
4,87 |
-3,93 |
|
Financial result |
0,30 |
0,11 |
0,19 |
|
RESULT BEFORE TAX |
1,23 |
4,98 |
-3,75 |
|
Taxes on profits |
-0,22 |
-1,39 |
1,17 |
|
RESULT COMING FROM CONTINUED OPERATIONS |
1,01 |
|
|
|
NET RESULT |
1,01 |
3,59 |
-2,58 |
|
|
COMPANY (2009) |
PTILE25 |
PTILE50 |
PTILE75 |
|
BALANCE RATIOS |
|
|
|
|
|
Working Capital (€) |
-347.819,00 |
853.522,48 |
1.896.586,35 |
3.658.494,87 |
|
Working capital ratio |
-0,02 |
0,12 |
0,31 |
0,46 |
|
Soundness Ratio |
0,39 |
1,20 |
4,03 |
10,42 |
|
Average Collection Period (days) |
96 |
57 |
93 |
164 |
|
Average Payment Period (days) |
89 |
11 |
33 |
73 |
|
LIQUIDITY RATIOS |
|
|
|
|
|
Current Ratio (%) |
97,62 |
1,18 |
1,57 |
2,07 |
|
Quick Ratio (%) |
2,51 |
0,02 |
0,09 |
0,38 |
|
DEBT RATIOS |
|
|
|
|
|
Borrowing percentage (%) |
47,77 |
3,45 |
23,96 |
44,64 |
|
External Financing Average Cost |
0,01 |
0,01 |
0,05 |
0,08 |
|
Debt Service Coverage |
-102,05 |
0,17 |
2,30 |
8,43 |
|
Interest Coverage |
3,27 |
1,87 |
5,35 |
29,81 |
|
GENERAL AND ACTIVITIES RATIOS |
|
|
|
|
|
Auto financing generated by sales (%) |
-0,30 |
1,29 |
2,93 |
6,56 |
|
Auto financing generated by Assets (%) |
-0,47 |
2,64 |
6,61 |
11,13 |
|
Breakdown Point |
1,01 |
1,01 |
1,03 |
1,08 |
|
Average Sales Volume per Employee |
1.132.390,16 |
198.178,09 |
389.295,59 |
721.288,34 |
|
Average Cost per Employee |
75.269,75 |
31.274,37 |
34.489,86 |
50.816,98 |
|
Assets Turnover |
1,58 |
1,18 |
1,78 |
2,53 |
|
Inventory Turnover (days) |
51 |
31 |
56 |
108 |
|
RESULTS RATIOS |
|
|
|
|
|
Return on Assets (ROA) (%) |
1,48 |
2,66 |
6,67 |
12,53 |
|
Operating Profitability (%) |
1,58 |
4,90 |
9,54 |
15,31 |
|
Return on Equity (ROE) (%) |
13,24 |
5,84 |
19,30 |
32,85 |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.45.20 |
|
|
1 |
Rs.73.17 |
|
Euro |
1 |
Rs.61.88 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any risk
and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its
officials.